As part of continuing transparency, we look forward to his reporting on the latest news from global pharma company Bristol Myers Squibbs. They've announced a partnership with Rockefeller University to produce not a vaccine but a potential treatment for Covid. So far, they've demonstrated that two complementary antibodies can neutralise the SARS-CoV-2 spike protein in laboratory and animal testing. Dr Veronique Walsh, also of Windsor, has worked for Bristol Myers Squibbs since 2010.
No comments:
Post a Comment